Master Protocols for Drug and Biological Product Development-2026/6/24

Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products-2026/6/24

Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials-2026/6/24

CVM GFI #109 (VICH GL15) Effectiveness of Anthelmintics: Specific Recommendations for Equines-2026/6/23

CVM GFI #110 (VICH GL16) Effectiveness of Anthelmintics: Specific Recommendations for Porcines-2026/6/23

CVM GFI #111 (VICH GL19) Effectiveness of Anthelmintics: Specific Recommendations for Canines-2026/6/23

CVM GFI #113 (VICH GL20) Effectiveness of Anthelmintics: Specific Recommendations for Felines-2026/6/23

CVM GFI #114 (VICH GL21) Effectiveness of Anthelmintics: Specific Recommendations for Chickens Gallus gallus-2026/6/23

CVM GFI #90 (VICH GL7) Effectiveness of Anthelmintics: General Recommendations-2026/6/23

CVM GFI #95 (VICH GL12) Effectiveness of Anthelmintics: Specific Recommendations for Bovines-2026/6/23